Home000538 • SHE
add
Yunnan Baiyao Group Co Ltd
Nakaraang pagsara
¥56.55
Sakop ng araw
¥56.65 - ¥57.60
Sakop ng taon
¥49.00 - ¥67.10
Market cap
102.18B CNY
Average na Volume
9.03M
P/E ratio
21.52
Dividend yield
4.19%
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.12B | 7.38% |
Gastos sa pagpapatakbo | 2.22B | -11.29% |
Net na kita | 422.69M | 1,523.41% |
Net profit margin | 4.18 | 1,406.25% |
Kita sa bawat share | 0.14 | 566.67% |
EBITDA | 461.05M | 318.89% |
Aktuwal na % ng binabayarang buwis | 34.86% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.02B | -17.64% |
Kabuuang asset | 52.91B | -1.62% |
Kabuuang sagutin | 14.05B | 1.22% |
Kabuuang equity | 38.87B | — |
Natitirang share | 1.78B | — |
Presyo para makapag-book | 2.60 | — |
Return on assets | 1.87% | — |
Return on capital | 2.51% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 422.69M | 1,523.41% |
Cash mula sa mga operasyon | 223.86M | -75.48% |
Cash mula sa pag-invest | -41.21M | -165.82% |
Cash mula sa financing | -3.32B | -1,656.12% |
Net change in cash | -3.13B | -382.23% |
Malayang cash flow | 1.17B | -60.77% |
Tungkol
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products.
The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species".
As of 2024 state, individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
Itinatag
1902
Website
Mga Empleyado
9,277
